655 related articles for article (PubMed ID: 30789748)
1. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
[TBL] [Abstract][Full Text] [Related]
2. [n-3 Polyunsaturated fatty acid attenuates hyperhomocysteinemia-induced hepatic steatosis by increasing hepatic LXA
Song H; Duan JJ; Li K; Yao L; Zhu Y
Sheng Li Xue Bao; 2021 Aug; 73(4):551-558. PubMed ID: 34405211
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice.
Yao L; Wang C; Zhang X; Peng L; Liu W; Zhang X; Liu Y; He J; Jiang C; Ai D; Zhu Y
Hepatology; 2016 Jul; 64(1):92-105. PubMed ID: 26928949
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice.
Liu Y; Dang H; Li D; Pang W; Hammock BD; Zhu Y
PLoS One; 2012; 7(6):e39165. PubMed ID: 22720061
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis.
Dong YQ; Zhang XZ; Sun LL; Zhang SY; Liu B; Liu HY; Wang X; Jiang CT
Acta Pharmacol Sin; 2017 Dec; 38(12):1601-1610. PubMed ID: 28933423
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.
Zhang D; Xie X; Chen Y; Hammock BD; Kong W; Zhu Y
Circ Res; 2012 Mar; 110(6):808-17. PubMed ID: 22354938
[TBL] [Abstract][Full Text] [Related]
7. Nox4 and soluble epoxide hydrolase synergistically mediate homocysteine-induced inflammation in vascular smooth muscle cells.
Liu X; Qin Z; Liu C; Song M; Luo X; Zhao H; Qian D; Chen J; Huang L
Vascul Pharmacol; 2019 Sep; 120():106544. PubMed ID: 30610956
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
9. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease.
Mello A; Hsu MF; Koike S; Chu B; Cheng J; Yang J; Morisseau C; Torok NJ; Hammock BD; Haj FG
Cell Mol Gastroenterol Hepatol; 2021; 11(3):815-830. PubMed ID: 33068774
[TBL] [Abstract][Full Text] [Related]
10. Soluble epoxide hydrolase and TRPC3 channels jointly contribute to homocysteine-induced cardiac hypertrophy: Interrelation and regulation by C/EBPβ.
Zhou Y; Wang XC; Wei JH; Xue HM; Sun WT; He GW; Yang Q
Biochim Biophys Acta Mol Basis Dis; 2023 Apr; 1869(4):166643. PubMed ID: 36669577
[TBL] [Abstract][Full Text] [Related]
11. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy.
Kim J; Yoon SP; Toews ML; Imig JD; Hwang SH; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2015 Jan; 308(2):F131-9. PubMed ID: 25377915
[TBL] [Abstract][Full Text] [Related]
13. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model.
Alwayn IP; Andersson C; Lee S; Arsenault DA; Bistrian BR; Gura KM; Nose V; Zauscher B; Moses M; Puder M
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1011-9. PubMed ID: 16844679
[TBL] [Abstract][Full Text] [Related]
15. Activation of peroxisome proliferator-activated receptor alpha by substituted urea-derived soluble epoxide hydrolase inhibitors.
Fang X; Hu S; Watanabe T; Weintraub NL; Snyder GD; Yao J; Liu Y; Shyy JY; Hammock BD; Spector AA
J Pharmacol Exp Ther; 2005 Jul; 314(1):260-70. PubMed ID: 15798002
[TBL] [Abstract][Full Text] [Related]
16. Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male mice.
Ip BC; Liu C; Lichtenstein AH; von Lintig J; Wang XD
J Nutr; 2015 Feb; 145(2):268-76. PubMed ID: 25644347
[TBL] [Abstract][Full Text] [Related]
17. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.
Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD
Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation.
Kim J; Imig JD; Yang J; Hammock BD; Padanilam BJ
Am J Physiol Renal Physiol; 2014 Oct; 307(8):F971-80. PubMed ID: 25164080
[TBL] [Abstract][Full Text] [Related]
19. Beyond detoxification: a role for mouse mEH in the hepatic metabolism of endogenous lipids.
Marowsky A; Meyer I; Erismann-Ebner K; Pellegrini G; Mule N; Arand M
Arch Toxicol; 2017 Nov; 91(11):3571-3585. PubMed ID: 28975360
[TBL] [Abstract][Full Text] [Related]
20. Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport.
Kawano Y; Nishiumi S; Tanaka S; Nobutani K; Miki A; Yano Y; Seo Y; Kutsumi H; Ashida H; Azuma T; Yoshida M
Arch Biochem Biophys; 2010 Dec; 504(2):221-7. PubMed ID: 20831858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
